Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02091011 · ClinicalTrials.gov registry record
LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,600
- Enrollment target
NCT02091011: Completed study, sponsored by Boston Scientific Corporation.
NCT02091011 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02091011 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,600 participants
- Enrollment target
Study Summary
The study is to determine the rate and cause of device replacements at 5 years post-implantation. It will assess the battery and device longevity of the Implantable Cardioverter Defibrillators (ICD) and CRT-D Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices. It will also validate the device survival information given in Boston Scientific's Product Performance Report by comparing the pulse generator (PG) survival probability in the study to that presented in the Product Performance Reports (PPR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2014-01-27 |
| Est. Completion | 2021-08 |
What the finished NCT02091011 record still lists
NCT02091011 is an observational study that tracks outcomes without assigning an intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02091011 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02091011 about?
NCT02091011 is a clinical study titled "LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices". The study is to determine the rate and cause of device replacements at 5 years post-implantation. It will assess the battery and device longevity of the Implantable Cardioverter Defibrillators (ICD) and CRT-D Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices. It will also validate the ...
What is the current status of trial NCT02091011?
This trial is currently completed. The enrollment target is 1,600 participants. The study started on 2014-01-27. Estimated completion is 2021-08.
Who is sponsoring clinical trial NCT02091011?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI